Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform

2022-06-24T22:14:33+00:00June 24th, 2022|Comments Off on Efficient and Scalable T Cell Engineering for Advancing Cancer Immunotherapy of Hepatocellular Carcinoma by a cGmp-Compliant Non-Viral Cell Engineering Platform
Read More

Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

2022-05-11T17:40:23+00:00May 10th, 2022|Comments Off on Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics
Read More

Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing

2022-04-22T18:40:17+00:00April 22nd, 2022|Comments Off on Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing
Read More

Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies

2022-03-19T14:44:04+00:00March 2nd, 2022|Comments Off on Electroporation of a Non-Integrative DNA Nanovector for Efficient, Semi-Automated, GMP Manufacturing of CAR T Cell Therapies
Read More

MaxCyte Flow Electroporation® Technology: A Safe, Reliable and Effective Method for Engineering CAR T Cells

2022-07-14T14:47:35+00:00December 6th, 2021|Comments Off on MaxCyte Flow Electroporation® Technology: A Safe, Reliable and Effective Method for Engineering CAR T Cells
Read More

MaxCyte, Inc.

9713 Key West Avenue
Suite 400
Rockville, MD 20850
Tel: +1-301-944-1700
Fax: +1-301-944-1703

Life Sciences

Consumables

Careers

Legal

Applications

Investors

ExPERT Platform

MaxCyte Minutes

Instruments

About Us

Resources

Distributors

Contact Ustwitter linkedin
Go to Top